ASAM Criteria 3rd Edition One-Day Foundations Course
Thursday, December 12, 2024 | 8:30am - 5:30pm ET
Virtual-Live Course

Overview

This 8-hour virtual-live course is the recommended first step to understanding the ASAM Criteria and covers developing patient-centered service plans as well as making objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. 

The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities. Learners will have the opportunity to ask the presenter questions in real time, participate in polling questions and break into small groups. 

The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

The target audience for this beginner, intermediate, and advanced course include: counselors, social workers, payers, administrators, and other clinical staff.

Learning Objectives

1. Describe the underlying principles and concepts of the ASAM Criteria
2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment
3. Determine treatment priorities based on risk assessment to guide treatment and service planning
4. Determine an appropriate level of care and treatment priorities based on risk assessment
5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 12/12/2024

Close Access Date: 1/12/2028

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 17 out of 24 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click Complete Presenter Evaluation to provide valuable feedback about presenters. Scroll down on all questions as there may be answer options that expand past the size of the window.
5. Click the button Claim Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Accreditation & Credit Designation Statements 

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The American Society of Addiction Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity awards 8 Nursing contact hours.

PAs

ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. Approval is valid until 11/12/2026. PAs should only claim credit commensurate with the extent of their participation.

Social Workers

As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 4 general continuing education credits.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 8 Interprofessional Continuing Education (IPCE) credits for learning and change.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Internal Medicine (ABIM)
• American Board of Pediatrics (ABP)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC)
  • Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Information

In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

Integration of a Community Opioid Treatment Program into a Federally Qualified Health Center

Published: November/December 2024
Journal Article

Overview

This one-hour, on-demand, journal article-based activity presents original research concerning the integration of a community Opioid Treatment Program (OTP) into a Federally Qualified Health Center (FQHC), an approach to expand access to methadone treatment and to promote retention in treatment among patients with opioid use disorder.  This study validates this model as a way to increase access to both treatment for OUD and primary care for urban, underserved patient populations.

The target audience for this intermediate continuing education activity includes: physicians, nurse practitioners, PAs, pharmacists and other clinicians, researchers, students, and policymakers.

This activity addresses the following ACGME Core Competencies: Patient Care, Medical Knowledge, Interpersonal and Communication Skills, Practice-Based Learning and Improvement, Professionalism, and Systems-Based Practice.

Article Abstract

Objectives
With the increasing rates of opioid overdose deaths in the United States, barriers to treatment access for patients seeking medications for opioid use disorder (OUD), and challenges of initiating buprenorphine in patients who use fentanyl, it is essential to explore novel approaches to expanding access to methadone treatment. An opioid treatment program (OTP) and a federally qualified health center (FQHC) partnered to develop and implement an innovative integrated methadone and primary care treatment model. The process for integrating an OTP and FQHC to provide methadone treatment in the primary care setting will be discussed

Methods 
An OTP methadone dispensing site was co-located in the FQHC, utilizing a staffing matrix built on the expertise of each stakeholder. The OTP managed DEA and state regulatory processes, whereas the FQHC physicians provided medical treatment, including methadone treatment protocols, treatment plans, and primary care. Patient demographics, medical history, and retention data for those who entered the program between January 2021 and February 2023 were collected through chart review and analyzed with descriptive statistics.

Results
A total of 288 OTP-FHQC patients were enrolled during the study. Retention rates in methadone treatment at 90 and 180 days were similar to partner clinics.

Conclusion
Collaboration between FQHCs and OTPs is operationally feasible and can be achieved utilizing the current staffing model of the FQHC and OTP. This model can increase access to treatment for OUD and primary care for an urban, underserved patient population.

Learning Objectives

Upon completion of this activity, learners will be able to:

1. Assess the feasibility of integrating federally qualified health centers with opioid treatment centers.
2. Discuss how barriers to accessing MOUD and primary care can be mitigated by the integrated care model for vulnerable patient populations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Open Registration: 08/01/2024 - 07/31/2027

Close Access Date: 08/31/2027

Course Instructions

1. Click on the Contents tab to begin this activity.
2. Click View Journal Article and read the journal article in its entirety. 
3. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
4. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
5. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Accreditation & Credits

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1 Credit(s)
• Physicians: 1 Credit(s)
• Nurses & NPs: 1 Nursing Contact Hour(s) 
• Pharmacists: 1 Credit(s)
• Certified Counselors: NBCC Contact Hours not offered

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1 Lifelong Learning 
• ABIM MOC Points: 1 Medical Knowledge 
• ABP MOC: 1 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1 Accredited CME 

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

  American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

MOCA 2.0® is a trademark of the American board of Anesthesiology®.
This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

The complete list of disclosures and designation statements are linked below.

Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants 
Published: November/December 2024

Journal Article

Overview

This one-hour, on-demand, journal article-based activity presents original research on the impact of the opioid intervention court (OIC) as an alternative to traditional treatment courts for people with OUD who are involved with the criminal-legal system and at high risk of overdose. The OICs more rapidly link court participants to treatment in comparison to traditional drug courts. As the time between arrest and post-arraignment drug court entry is one of high risk and may suspend access to treatment for OUD, OICs may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants.

The target audience for this intermediate continuing education activity includes: physicians, nurse practitioners, PAs, pharmacists and other clinicians, researchers, students, and policymakers.

This activity addresses the following ACGME Core Competencies: Patient Care, Medical Knowledge, Interpersonal and Communication Skills, Practice-Based Learning and Improvement, Professionalism, and Systems-Based Practice.

Article Abstract

Objective
The opioid intervention court (OIC) is an innovative, pre-plea treatment court to facilitate rapid linkage to medications for opioid use disorder (MOUD) for people at risk of overdose. This study compares participants in OIC and participants with opioid use problems in a traditional drug treatment court model on (i) initiation for any substance use (SU) treatment, (ii) initiation of MOUD, (iii) number of days to MOUD initiation, and (iv) retention in the OIC program/retention on MOUD.

Methods
We used administrative court records from n = 389 OIC and n = 229 drug court participants in 2 counties in New York State. Differences in outcomes by court were assessed using logistic, multinomial, or linear regressions.

Results
After adjusting for current charge severity, gender, race/ethnicity, age, and county, OIC participants were no more likely to initiate any SU treatment but were significantly more likely to initiate MOUD (81.2% OIC vs 45.9% drug court, P < 0.001) and were more quickly linked to any SU treatment (hazard ratio = 1.68, 95% confidence interval = 1.35–2.08) and MOUD (hazard ratio = 4.25, 95% confidence interval = 3.23–5.58) after starting the court. Retention in court/MOUD was higher among drug court participants and may speak to the immediate sanctions (eg, jail) for noncompliance with drug court directives as compared with opioid court, which does not carry such immediate sanctions for noncompliance.

Conclusion
These analyses suggest that the new OIC model can more rapidly link participants to treatment, including MOUD, as compared with traditional drug court model, and may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants.

Learning Objectives

Upon completion of this activity, learners will be able to:

1. Discuss how the opioid intervention court (OIC) model may serve as an alternative to traditional treatment courts for people with OUD who are involved with the criminal-legal system.

2. Compare the opioid intervention court (OIC) to traditional drug courts in terms of factors that impact overdose risk, retention in treatment, legal sanctions, and recidivism for participants. 

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Open Registration: 08/01/2024 - 07/31/2027

Close Access Date: 08/31/2027

Course Instructions

1. Click on the Contents tab to begin this activity.
2. Click View Journal Article and read the journal article in its entirety. 
3. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
4. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
5. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Accreditation & Credits

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1 Credit(s)
• Certified Counselors: NBCC Contact Hours not offered

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1 Lifelong Learning | 1 Patient Safety
• ABIM MOC Points: 1 Medical Knowledge | 1 Patient Safety
• ABP MOC: 1 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1 Accredited CME | 1 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

  American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

MOCA 2.0® is a trademark of the American board of Anesthesiology®.
This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

The complete list of disclosures and designation statements are linked below.

Stimulants

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

According to the CDC, from 2012 through 2020 in the United States, the number of deaths involving methamphetamine increased more than 6-fold while the number of deaths involving cocaine more than tripled. This session will focus on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more. 

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Novel Approaches to the Prevention and Treatment of Stimulant Use Disorders
  This presentation will summarize prevention and treatment recommendations from the new ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. Key takeaways from the guideline will be discussed. Topics for discussion will include behavioral and pharmacological treatments, co-occurring conditions, management of stimulant intoxication and withdrawal, and secondary and tertiary prevention strategies to reduce harms associated with risky stimulant use.
• Mosaic Approaches to Understanding ADHD and Stimulant Use Disorders
  This session provides an overview of ADHD, including diagnostic criteria and key characteristics, with a focus on understanding the overlap between ADHD and substance use disorders. Participants will explore methods to reduce stimulant misuse and examine the trajectories of substance use disorders in individuals with ADHD. The discussion will also highlight how the COVID-19 pandemic shifted diversion sources among adolescents and young adults, emphasizing the evolving nature of these challenges.
• BEAT Meth: New Findings for Advancing Methamphetamine Addiction Treatment
  The pathophysiology of methamphetamine addiction--including its intense biological reinforcement and symptom profile--poses challenges for prevention and treatment. Attendees will hear original findings from BEAT Meth, a CDC-funded project that applies a multifaceted public health approach to addressing methamphetamine addiction. These findings include strategies to describe methamphetamine-related healthcare utilization; diagnostic criteria for methamphetamine-induced psychotic disorders; and adaptation of contingency management to support linkage to care.
• Development of Dual-Acting Sigma and Dopamine Transporter Inhibitors as Potential Pharmacotherapy for Stimulant Use Disorders
  This session will describe a novel pharmacotherapy mechanism of treating stimulant use disorder.   The attendees will be able to explain the necessity for the dual mechanism of action in the drugs ability to attenuate rodents from self-administering cocaine.  This session will also demonstrate the success of this concept, the challenges that are still ahead with drug development, and the potential for this treatment to be game changing as an aid in the treatment of stimulant use disorders.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2 Credit(s)
• Nurses & NPs: 2 Nursing Contact Hour(s)
• Pharmacology Hour(s): 1.75 Hour(s)
• PAs: 2 Credit(s)
• Pharmacists: 2 Credit(s)
• Interprofessional Continuing Education: 2 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2 Lifelong Learning
• ABIM MOC Points: 2 Medical Knowledge
• ABP MOC: 2 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2 Accredited CME | 2 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Federal Agency Session

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

During this 1-hour, on-demand session from the 2024 ASAM State of the Art Course, federal agency leaders from NIAAA, SAMHSA, and NIDA give brief overviews about emerging issues and advances in addiction medicine from their respective organizations. Following the presentations, ASAM President, Dr. Brian Hurley, leads the agencies in a lively discussion about the most pressing topics in addiction medicine.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1.00 Credit(s)
• Nurses & NPs: 1.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): Not offered
• PAs: 1.00 Credit(s)
• Pharmacists: 1.00 Credit(s)
• Interprofessional Continuing Education: 1.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1.00 Lifelong Learning
• ABIM MOC Points: 1.00 Medical Knowledge
• ABP MOC: 1.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1.00 Accredited CME | 1.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Cannabis

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Cannabis is the most used federally illegal drug in the United States. With a growing market and shrinking perception of harm among the general population, the last several years have seen a steady increase in research on cannabis and its relative benefits and harms. This session will outline recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This session is comprised of 2 presentations and a panel that dive deep into different aspects of the overall topic.

• Using Human Laboratory Studies to Characterize the Effects of Novel Cannabis Products, Formulations, and Routes of Administration
  This session will showcase data from the Johns Hopkins Cannabis Science Lab which conducts controlled human dosing studies to understand the effects of cannabis. Research projects presented include systematic studies to characterize the impact of dose, route of administration, and product formulation, as well as studies designed to determine driving impairment associated with cannabis use.
• How Laboratory Science Can Inform Cannabis Use Prevention, Treatment, and Regulation
  This session will review current data on the use of cannabis in medical settings. These data will include an overview of the possible clinical benefits and adverse effects of cannabis. Topics covered will include drug-drug interactions with other medications, effects of acute and chronic cannabis on mental health and performance, and potential for abuse and dependence. Methods described will include laboratory assessments, real-world treatment tracking, and epidemiological data.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1.00 Credit(s)
• Nurses & NPs: 1.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): Not offered
• PAs: 1.00 Credit(s)
• Pharmacists: 1.00 Credit(s)
• Interprofessional Continuing Education: 1.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1.00 Lifelong Learning
• ABIM MOC Points: 1.00 Medical Knowledge
• ABP MOC: 1.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1.00 Accredited CME | 1.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Nicotine

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Smoking remains the leading cause of preventable disease and death in the US, killing more than 480,000 Americans each year. Smoking cessation is possible and can save lives. This session will discuss tobacco use in different populations, GLP-1 use for smoking cessation, comparative effectiveness of treatment models, and more, to provide a comprehensive overview of the state of the art of treatment for nicotine use disorder. 

This session is comprised of 4 presentations and a panel that dive deep into different aspects of the overall topic.

• Adaptive Trials for Tobacco Cessation
  This session will review clinical trials testing the development or comparative effectiveness of adaptive tobacco cessation treatment models which adapt individual cessation treatment based on user response. The session will further explore the strengths and limitations of different trial designs and assess the generalizability of adaptive treatment research findings for use in clinical practice.
• GLP-1 Agonists for the Treatment of Nicotine Dependence and Post-Cessation Weight Management: The Skinny on Novel Anti-Obesity Medications
  Despite tremendous health benefits, smoking cessation leads to an increased consumption of highly palatable foods. As a result, the majority of former smokers gain weight after quitting. Post-cessation weight gain (PCWG) can decrease smoking cessation motivation and success, and it can have detrimental effects on metabolic health in those who do achieve abstinence. This presentation will focus on the potential utility of glucagon-like peptide 1 receptor agonists (GLP1-RA) for addressing tobacco smoking and post-cessation weight management.  The author will discuss the overall state of the science on targeting GLP-1Rs to reduce tobacco smoking and PCWG, with the primary focus on the completed and ongoing clinical trials conducted by our group. Directions for future clinical research will be provided.
• Tobacco Use among Older Adults: A Forgotten Population
  The number of adults 65 years and older is projected to nearly double between 2012 and 2050, prompting global efforts to address the inevitable challenges of this population shift. Of concern is the parallel observation that tobacco smoking prevalence in the US and other countries has declined considerably for all age groups except for those 65 and older. Given these trends, it is likely that the absolute number of older adults who smoke will increase in the coming years. This presentation will explore these trends and address older adults' interest in quitting and cessation rates. The presentation will also expand on the recently published ASAM Criteria (4th Ed) chapter on tobacco use, focusing on older adults and harm reduction approaches.
• Novel and Emerging Interventions for Patients Unwilling to Quit
  Smoking tobacco cigarettes is associated with premature mortality. Quitting smoking can help people gain between 3 to 10 Quality Adjusted Life Years (QALYs). However, even the best evidence-based treatments have low absolute quit rates. Repeated attempts are associated with greater success and should be encouraged. Unfortunately, some populations such as those with concurrent addictions and or mental illness are "treatment resistant". This session will present emerging evidence on novel and new interventions (e.g. brain stimulation) that could help them stop smoking cigarettes for good. In addition, this session will invite attendees to appraise the evidence for off-label use of existing treatments including combination, higher doses, extended treatment, and lower risk nicotine use guidelines.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): .5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

Alcohol

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

According to 2023 national data, 10% of individuals ages 12 and older met criteria for an alcohol use disorder (AUD) in the past year. This indicates an urgent need for effective and innovative approaches to meet the needs of this large treatment population. This session will examine new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Spironolactone in Alcohol Addiction: A Translational Approach
  This session will review recent work conducted in animal models, including mice, rats, and non-human primates, as well as recent work in humans, including in people with alcohol use disorder, that has been conducted on (1) the relationship between aldosterone and alcohol drinking and dependence, and (2) the potential role of spironolactone in alcohol use disorder.
• Psychedelics for the Treatment of Alcohol Use Disorder
  The session will describe  the results of completed trials of investigational psychedelic medications in the treatment to alcohol use disorder. Evidence for safety and efficacy will be evaluated, and possible mechanisms of action will be discussed based on currently available data. The prevention will also discuss possible next steps toward clinical use and safe and equitable dissemination of new treatments should they become available for clinical use.
• Repurposing the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide to Treat Alcohol Use Disorder
  Anecdotal reports of the efficacy of semaglutide and other Glucagon-Like Peptide-1 (GLP-1) receptor agonists as medical therapies for obesity have garnered widespread public attention, engendering ethical debates and leading to worldwide drug shortages.  This brief presentation will update participants about the National Institute on Drug Abuse Intramural Research Program's ongoing early phase clinical trial studying the exciting possibility of repurposing semaglutide to treat patients with alcohol use disorder.
• Technology-Assisted Approaches to Facilitate Remotely Delivered Alcohol Use Disorder Treatment
  This session will provide an overview of recent research that has involved remotely delivered alcohol use disorder treatment. Covered topics will include the key elements of treatment delivery that can be facilitated by technology, the types of devices and their features that have been useful for this research, and results from randomized clinical trials employing these techniques. Overall, results will demonstrate that technology-assisted approaches to alcohol use disorder treatment delivery can demonstrate high degrees of efficacy while overcoming some of the treatment-access barriers associated with in-person treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2 Credit(s)
• Nurses & NPs: 2 Nursing Contact Hour(s)
• Pharmacology Hour(s): 1 Hour(s)
• PAs: 2 Credit(s)
• Pharmacists: 2 Credit(s)
• Interprofessional Continuing Education: 2 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2 Lifelong Learning
• ABIM MOC Points: 2 Medical Knowledge
• ABP MOC: 2 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2 Accredited CME | 2 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

ASAM State of the Art Course Addiction Medicine 2024

Recorded on Thursday, October 17 - Friday, October 18, 2024

On-Demand Course

Overview

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner’s practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Content tab to view all sessions within the course. Click the View button to access a specific session.
2. Within each session, select the Content tab to begin the activity.
3. Participants will need to complete posttests and evaluations after each session. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly. Medical Credits are claimed within each session and are not available for the entire package.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Accreditation & Credits

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 16 Credit(s)
• Nurses & NPs: 16 Nursing Contact Hour(s)
• Pharmacology Hour(s): 6.5 Hour(s)
• PAs: 16 Credit(s)
• Pharmacists: 16 Credit(s)
• Interprofessional Continuing Education: 16 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 16 Lifelong Learning
• ABIM MOC Points: 16 Medical Knowledge
• ABP MOC: 16 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 16 Accredited CME | 16 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventive Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.

  American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

MOCA 2.0® is a trademark of the American board of Anesthesiology®.
This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

The complete list of disclosures and designation statements are linked below.

Presenter Disclosures

Innovations in Technology

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Recent innovations in addiction treatment technology are transforming clinical care. These advancements provide novel, personalized treatment options, facilitate real-time communication with healthcare providers, and promote engagement in recovery and harm reduction. This session will discuss new approaches such as tele-harm reduction, brain stimulation, and more.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Harnessing Digital Health in the Assessment and Treatment of Substance Use Disorders
  This session explores the role of digital health technologies in the assessment and treatment of substance use disorders. Attendees will learn about innovative digital tools that enhance screening accuracy, personalize treatment, and improve patient engagement. The discussion will cover the benefits, challenges, and ethical considerations of using digital health in clinical practice, as well as its potential to transform substance use care. 

• Tele-Harm Reduction
  This session will introduce Tele-Harm Reduction (THR) as a crucial and innovative tool towards ending the HIV epidemic. THR leverages telehealth technology to deliver comprehensive care within syringe services programs (SSPs). T-SHARP is a clinical trial that aims to improve HIV outcomes among people who inject drugs (PWID). The trial evaluates the efficacy of this telehealth intervention in achieving viral suppression, initiating medications for opioid use disorder (MOUD), and curing hepatitis C. By bridging the digital divide and meeting PWID where they are, T-SHARP seeks to transform HIV care delivery and improve clinical outcomes.
• Randomized Repetitive Transcranial Magnetic Stimulation Trial for Smoking Cessation
  A comparison of 1 Hz rTMS over the medial frontal cortex and 10 Hz rTMS over the dorsolateral prefrontal cortex was completed in healthy smokers. Results showed that 10 Hz rTMS reduced cigarette consumption more than 1 Hz rTMS as well as sham TMS. 10 Hz treatment increased brain activity in the lateral prefrontal cortex and decreased brain activity in the medial frontal cortex. The study demonstrates that 10 Hz rTMS stimulation of the dorsolateral prefrontal cortex in an executive control circuit may be better for developing brain stimulation treatment than 1Hz rTMS of the medial orbitofrontal cortex in a medial reward circuit.
• Primary and Secondary Findings from the NIDA CTN ADAPT-2 Trial in Relation to the Treatment of Methamphetamine Use Disorder
  This session will delve into the cutting-edge research and treatment options for stimulant use disorders. Participants will learn about the latest pharmacotherapy developments and the significance of biomarker research in enhancing treatment efficacy. The discussion will also cover the challenges faced in treating stimulant use disorders and propose innovative solutions. Overall, the session aims to provide a comprehensive understanding of the evolving landscape of stimulant use disorder treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

DEA Education Requirement

As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 2 hours of the DEA requirement for 8 hours of education on substance use disorder(s).

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 11/01/2024 - 10/01/2027

User Access Closed: 11/01/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 2.00 Credit(s)
• Nurses & NPs: 2.00 Nursing Contact Hour(s)
• Pharmacology Hour(s): 0.5 Hour(s)
• PAs: 2.00 Credit(s)
• Pharmacists: 2.00 Credit(s)
• Interprofessional Continuing Education: 2.00 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

Note for pharmacists: Not all courses offer CPE Credit. For courses that do offer CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab. For any questions or concerns, please e-mail Education@ASAM.org

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 2.00 Lifelong Learning
• ABIM MOC Points: 2.00 Medical Knowledge
• ABP MOC: 2.00 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 2.00 Accredited CME | 2.00 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.